Fell almost 20% today!
Anyone live near their Scottish works (or Newcastle upon Tyne region)....can comment on activity, staffing etc?

I wonder what their cash position is, bearing in mind they have floated Nov2005 and already the sp is nearly halved.....oh dear!
Could be lack of news, or....... news that dare not speak its....

Not a holder but interested to learn more, they have a deal with Neuron and some Government body, but this may be short-lived I guess. Based on stem-cell research/production this is a Political area where Public minds can change rapidly.
If it is Gov funding then this can be cut overnight, or something nasty eascapes (or Newspapers say it has escaped, etc)

I note that the spread is a robust 40%, now why is that? (very low volumes?-dunno.)
Anyone holding?

RNS confirms the Co is in discussion . . . .

Well, it's nice to know the Execs are awake, even though they took their time to shake the sleep out of their eyes. It is about time Company Execs took care of their responsibilities . . . . not by waiting unil the News is "out" - but well in advance!

Leaves a nasty Whiff, IMHO.

EDIT Oct08 - after slight rise, methinks BargePoles....

Angel Biotechnology Issue of Equity




RNS Number : 4108W
Angel Biotechnology Holdings Plc
11 June 2008


Wednesday 11 June 2008

Angel Biotechnology Holdings plc
("the Company")
Issue of Equity

The Company announces that application has been made for the admission to trading on AIM
of 7,357,142 Ordinary Shares of 0.1p nominal
value. Admission is expected to take place on 13 June 2008.

The shares have been issued following the exercise of warrants at a price of 0.175p per
share.


For further information:

Angel Biotechnology Holdings plc 07747 842446
Dr Paul Harper, Chairman

Grant Thornton Corporate Finance 020 7383 5100
Philip Secrett, Colin Aaronson

I found the original thread. Can't be that hard if I can do it!

? what's wrong with the other thread ?

What next for the SP.... it's been looking strong the past couple of weeks..hopefully it'll continue that way.

Good report and now in profit, with good order book.
Highlights:
Business Highlights for the period are:



The Company made a net profit in H1 2010 of 106,737. We expect this trend to continue and look forward to announcing a net profit for the full year 2010.

Net liabilities have reduced from 1.6m (Dec 09) to 100,000.

Eight new contracts were signed and two contracts were extended in the period, with a total value of more than 3.3m.

More than 92% of 2010 budgeted business has been signed and almost 40% of the business budgeted for 2011.

Three of the new contracts signed were specifically to provide regulatory support.

Successfully raised 1.425m before expenses through Hybridan acting as broker, to provide working capital and to facilitate an expansion of the companies resource

Appointed Lorna Peers as Group Financial Controller and Company Secretary





Gordon Sherriff, COO of Angel Biotechnology Holdings Plc, said:



"Angel has enjoyed a successful and productive first 6 months of 2010. In addition to making our first ever half year profit, we have now secured most of the business required to deliver our plan for 2010.

The business development team continue to secure new business for 2011, currently amounting to almost 40% of our target and we expect to remain profitable in H2 of 2010, to record the first annual profit in our history. This is a remarkable achievement by the Company in a market that remains challenging. This is a testament to the determined efforts of the business development team to secure new business and the operational team to deliver our clients milestones. The Directors are confident that the business has turned an important corner and we expect to be able to build on this success.